Nonbleeding complications of unfractionated and low-molecular weight heparins.
Eikelboom
John
J
Thrombosis Service, Hamilton General Hospital, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
D000925:Anticoagulants / Q000009:adverse effects*; D001384:Azetidines / Q000494:pharmacology; D001596:Benzylamines / Q000494:pharmacology; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000187:drug effects*; D011134:Polysaccharides / Q000494:pharmacology; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; C426686:ximelagatran; D000077425:Fondaparinux